Graham Erwin, Ph.D., is a Stanford Cancer Institute Postdoctoral Fellow in the Department of Genetics at Stanford University. He is a molecular, chemical and genome biologist elucidating the functional role of repetitive, so-called "junk" DNA sequences. This work is guiding the design of new therapeutics and diagnostics for human disease.

He received his Ph.D. from the University of Wisconsin-Madison, where he was a co-inventor of synthetic transcription factors to treat devastating neurodegenerative diseases. The resulting patents formed the basis of Design Therapeutics (San Diego, California).

He has published first-author papers in high-impact journals including PNAS and Science.
Graham is a strong advocate for programs that support mental health and psychological thriving.